Clinical trial

Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to…

NCT00121472 · Abbott Medical Devices, Industry · Completed

Key facts

NCT number NCT00121472
Title Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Bridge to Cardiac Transplantation
Official title The HeartMate II LVAS Pivotal Study Protocol, Bridge to Cardiac Transplantation
Lead sponsor Abbott Medical Devices, Industry
Collaborators Thoratec Corporation Industry
Status Completed
Study type Interventional
Conditions Heart Failure, Congestive, Ventricular Dysfunction, Cardiomyopathies
Intervention type Device
Interventions Thoratec HeartMate II Left Ventricular Assist System (LVAS)
Enrollment 194
Start date Mar 1, 2005
Primary completion Nov 1, 2006
Completion May 1, 2010
First posted Jul 21, 2005
Last update posted Jun 27, 2022
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies